Rupa Cornell

Vice President and Chief Compliance Officer at Astria Therapeutics

Speaker

Rupa Cornell is a biotechnology legal and compliance executive with more than 25 years of experience in the life sciences industry. Most recently, she served as Vice President and Chief Compliance Officer at Astria Therapeutics, where she helped build the company’s global compliance program and prepare the organization for its successful acquisition in January 2026. Previously, she was VP and Head Counsel for the Vaccine Business Unit at Takeda, supporting the launch of the company’s first global dengue vaccine. Rupa has also held senior legal roles at Biogen, Sage Therapeutics, Stallergenes Greer, and Stealth BioTherapeutics, and began her in-house career at Boston Scientific, a global medical device company. She serves on the boards of the Massachusetts Technology Collaborative and Next Generation Investment.